oxaliplatin
Showing 26 - 50 of 922
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Trial (Oxaliplatin)
Not yet recruiting
- Lung Metastases
- +2 more
- Oxaliplatin
- (no location specified)
Nov 3, 2022
Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)
Terminated
- Non-hodgkin Lymphoma,B Cell
- +2 more
- MT-3724
- +2 more
-
Orange, California
- +8 more
Jul 18, 2022
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- S1
- +3 more
-
Hangzhou, Zhejiang, China
- +4 more
May 23, 2023
Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)
Completed
- Gastric Cancer
- GastroEsophageal Cancer
- SHR-1210
- +3 more
-
Hefei, Anhui, China
- +9 more
Jun 30, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)
Withdrawn
- Metastatic Colorectal Cancer
- Oxaliplatin
- +4 more
-
Herlev, DenmarkHerlev University Hospital, Department of Oncology
Oct 19, 2021
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)
Recruiting
- Colorectal Adenocarcinoma
- Oesogastric
- Trifluridine/Tipiracil
- Oxaliplatin
-
Besançon, France
- +10 more
Jan 28, 2022
Colorectal Cancer, Peritoneal Metastases Trial in Sweden (5Fluorouracil, Irinotecan, Oxaliplatin)
Recruiting
- Colorectal Cancer
- Peritoneal Metastases
- 5Fluorouracil
- +2 more
-
Gothenburg, Sweden
- +3 more
Oct 12, 2021
Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Trifluridine/Tipiracil
- +2 more
-
Amiens, France
- +20 more
Jul 26, 2022
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel
Completed
- Gastric Cancer in Situ
- +2 more
- Oxaliplatin
- +3 more
-
Taipei, TaiwanTaiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022
Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)
Recruiting
- Colorectal Carcinoma
- Sintilimab
- +2 more
-
Guangzhou, ChinaSun Yat-sen University
Dec 29, 2022
Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)
Terminated
- Colorectal Cancer
- +2 more
- Oxaliplatin
- mFOLFIRI
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 21, 2021
Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)
Not yet recruiting
- Locally Advanced Unresectable Gastric Adenocarcinoma
- Oxaliplatin
- +2 more
-
Tianjin, Tianjin, ChinaXuewei Ding
Aug 2, 2023